Physician profile
Mark A Burroughs
NPI 1881155919
$12,907.19
in general payments reported to CMS, 2019-2025
28 companies · $2,533 in 2025
The $2,533 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $579 · 2021: $2,230 · 2022: $428 · 2023: $542 · 2024: $6,456 · 2025: $2,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,750 · Travel and Lodging: $2,339 · Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,750.00 |
| Travel and Lodging | $2,339.21 |
| Food and Beverage | $1,441.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,149.67 | 2021-2025 | |
| Stryker Corporation | $333.38 | 2020-2023 | Spy-Phi System |
| Medical Device Business Services, INC. | $305.00 | 2020 | |
| Ethicon US, LLC | $266.35 | 2020-2024 | Echelon Flex, Enseal X1, Surgicel Nu-Knit |
| Abbvie INC. | $229.25 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Davol INC. | $228.78 | 2023-2024 | Arista Ah Flexitip |
| Kci USA, INC. | $205.10 | 2020-2023 | Abthera, Prevena, V.A.C.Ulta |
| Tela Bio, INC. | $202.14 | 2022-2024 | Ovitex 2s |
| Csl Behring | $191.49 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $104.65 | 2021-2022 | |
| Allergan, INC. | $101.98 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $89.97 | 2023 | |
| Pfizer INC. | $87.29 | 2019-2022 | |
| Novo Nordisk INC | $50.05 | 2025 | Wegovy |
| Solventum Corporation | $40.79 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $40.25 | 2023 | Xenosure Biologic Patch |
| Takeda Pharmaceuticals U.S.A., INC. | $39.01 | 2025 | Gattex |
| Phathom Pharmaceuticals, INC. | $31.48 | 2024-2025 | Voquezna |
| Boston Scientific Corporation | $29.42 | 2023-2025 | Spyglass, Enhance Transcarotid Peripheral Access Kit |
| Intra-Sana Laboratories | $26.06 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Pacira Pharmaceuticals Incorporated | $26.03 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $24.65 | 2019 | |
| Avanos Medical | $21.43 | 2022 | |
| Urgo Medical North America, LLC | $18.53 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Cook Medical LLC | $17.75 | 2020 | |
| Medtronic, INC. | $16.27 | 2023 | Signia |
| Teleflex LLC | $15.83 | 2019 | |
| Nestle Healthcare Nutrition INC. | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Burroughs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.